Stone Pharmaceutical Innovation (300765.SZ) subsidiary Sitcumab injection application for listing has been accepted.

Zhifubao Finance and Economics APP News, Shiyao Innovation (300765.SZ) announced that its controlling subsidiary, Shiyao Group Jushi Biopharmaceutical Co., Ltd., recently received an "Acceptance Notice" issued by the National Medical Products Administration. The application for the market approval of Sikuzhiyou Monoclonal Antibody Injection has been accepted.